- U.S.
midterm elections signal growing fortunes for cannabis industries with
pro-cannabis voting, ouster of anti-cannabis attorney general
- Phivida
among cannabis industry companies that enjoy stock boost in immediate wake
of elections
- Phivida
enthused by new FDA and DEA acceptance of natural cannabis in
pharmaceuticals, which opens prospects for non-FDA administered products
as well
- Company
announces appointment of new senior vice president of distribution to
optimize placement of its products in functional food and beverage markets
A rolling groundswell of progressive developments in the
cannabis use seascape, driven by winds of change in North America’s political
arenas, is underscoring the optimism of hemp-derived cannabinoid product maker
Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) as the company builds its
product line with a view on the industry’s horizon.
In the immediate aftermath of November’s midterm elections
in the United States, market shares of cannabis-related companies, including
Phivida, “traded broadly, and in many cases sharply higher” following activity
that had media publications such as Forbes (http://ibn.fm/iEon8) declaring that “Marijuana Won The
Midterm Elections” and MarketWatch (http://ibn.fm/iVFQe) predicting the commencement of a
“green wave.”
Among the forces driving the exuberance were news that
Michigan had become the tenth state (plus Washington, DC) to legalize
recreational marijuana use and that medicinal marijuana extract use won over
voters in Utah and Missouri, solidly securing more than half of U.S. states in
the medical use camp despite ongoing disdain at the federal level.
But even the federal government has been signaling a slow
U-turn on its prohibition of cannabis use. Congressional legislators have been
preparing to deregulate hemp cultivation in the agricultural industry, and the
House of Representatives’ swing toward the Democratic camp in the elections
likely assures that it will happen in the near future, if agreements stall this
year. Cannabis advocates also celebrated the ouster of Attorney General Jeff
Sessions, the nation’s top law enforcement official, noted for his opposition
to cannabis legalization, following the elections.
Phivida also celebrated the U.S. Food and Drug
Administration’s recent approval of the first pharmaceutical with natural
cannabis as an ingredient, which forced the Drug Enforcement Administration to
reclassify cannabidiol (CBD) from its restricted Schedule 1 drug status to the
far more legally accessible Schedule 5, albeit on a basis limited only to products
approved by the FDA (http://ibn.fm/yLcUA).
“We see this reclassification of CBD in pharmaceuticals as a
good sign that will bolster the growing awareness of CBD as a substance that
delivers many benefits, and opens the door for other CBD-based treatments, in
line with the recent FDA approval of a drug to treat childhood epilepsy,”
Phivida President and CEO Jim Bailey stated in a news release. “Phivida is
launching its Oki line of functional beverages which provide a spectrum of
non-psychoactive phytocannabinoids through infusion with active hemp extract.
While our Oki and Vida+ product lines are not subject to FDA approval, as we
grow to have product on shelves in all 50 states, we will benefit from the
increased acceptance of the efficacy of cannabis and hemp products.”
Phivida launched its Oki brand (www.FeelOki.com) of active
hemp-infused functional beverages and supplements on September 12, anticipating
consumer availability in up to 2,400 natural specialty stores nationwide, which
could include access to major chains such as Whole Foods, Sprouts, Walmart,
Publix and Albertsons. The company’s Vida+ brand (www.HempVidaPlus.com)
of CBD hemp oil extracts, tinctures and capsules target a broad market, and the
company’s August 15 announcement that it will partner with licensed Canadian
medical marijuana producer WeedMD Inc. (TSX.V: WMD) (OTCQX: WDDMF) (FSE: 4WE)
to establish Cannabis Beverages Inc. (“CanBev”) opens even further
possibilities in the Canadian market (http://ibn.fm/AUZbR).
On November 2, Phivida announced the appointment of Greg
McCauley as its senior vice president of distribution (http://ibn.fm/fg3kz) to optimize
the company’s presence in the high-growth premium functional food and beverage
markets.
“He has a solid track record of building distribution
networks to launch new brands and realign established brands in the United
States and Canada and has consistently beat operational targets,” Bailey noted.
“Greg will initially focus on building out the U.S. distribution market for our
Oki beverage and health supplement line in conjunction with our partners at
Acosta/Natural Specialty Sales.”
McCauley brings with him over 30 years of professional
networking and experience in the consumer products industry with major brands
such as Jägermeister, Muscle Milk and Red Bull.
For more information, visit the company’s website at www.Phivida.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment